ArticleCPT: pharmacometrics & systems pharmacology2024

Bayesian sparse regression for exposure-response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T-cell leukemia/lymphoma.

Masato Fukae et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.